Identification of IGF1R mutation as a novel predictor of efficacious immunotherapy in melanoma

J Transl Med. 2022 Apr 11;20(1):172. doi: 10.1186/s12967-022-03324-8.

¹ Department of Pathology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
² The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing Simcere Medical Laboratory Science Co., Ltd, The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co. Ltd, Building 5, No. 699-18 Xuanwu Avenue, Xuanwu District, Nanjing, Jiangsu, China.
³ Department of Pathology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. LiuHui_20220225@163.com.

No abstract available

Publication types